The amount of visceral fat reduction significantly decreases the risk of cardiovascular events, type 2 diabetes, and several cancers
Weight regain is possible when stopping GLP-1 medications, as the appetite-suppressing effects diminish
McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER
However, whether excess hemin exposure from the hemolysis in SCD will affect CBS expression and the generation of GSH in oxidative and ferroptosis stress response has not been investigated
Thus, GLP-1 RAs are considered effective in promoting insulin secretion and inhibiting glucagon secretion by targeting most of the defects associated with the pathogenesis of T2DM [16]